Pharma

Your Article Summary

See Latest Articles

Genzyme Provides Update on Cerezyme Supply and 2009 Financial Information
Genzyme, 08/11/09

Genzyme Corp. provided an update on the impact of Cerezyme supply constraints on patient treatment regimens and on the company's 2009 financial results. The company's Fabrazyme supply constraint period, Fabrazyme dose conservation guidelines for patients, and Fabrazyme financial guidance are unchanged.

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09

CPSI Profits Down, Revenue Up
HealthDataManagement, 11/02/09

Antigenics Reports Third Quarter 2009 Financial Results
Antigenics, 11/05/09

See All of Financial Reports